메뉴 건너뛰기




Volumn 9, Issue 10, 2013, Pages 2211-2215

Antibiotic-free production of a herpes simplex virus 2 DNA vaccine in a high yield cGMP process

Author keywords

Antibiotic free; DNA vaccine; Downstream processing; Escherichia coli; Fermentation; HSV 2; Plasmid

Indexed keywords

ANTIBIOTIC AGENT; DNA VACCINE; ENDOTOXIN; GENOMIC DNA; GLYCOPROTEIN D; HERPES SIMPLEX NTC8485 O2 GD2 VACCINE; HERPES SIMPLEX NTC8485 O2 UGD2TR VACCINE; HERPES SIMPLEX VACCINE; PLASMID DNA; PLASMID VECTOR; UNCLASSIFIED DRUG;

EID: 84885119336     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.25048     Document Type: Article
Times cited : (18)

References (12)
  • 1
    • 70349620998 scopus 로고    scopus 로고
    • Maternal and neonatal herpes simplex virus infections
    • PMID: 19797284
    • Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med 2009;361:1376-85; PMID: 19797284; http://dx.doi.org/10.1056/ NEJMra0807633
    • (2009) N Engl J Med , vol.361 , pp. 1376-1385
    • Corey, L.1    Wald, A.2
  • 2
    • 84876211366 scopus 로고    scopus 로고
    • Current trends in negative immunosynergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2
    • PMID:23355766
    • Chentoufi AA, Dervillez X, Rubbo PA, Kuo T, Zhang X, Nagot N, et al. Current trends in negative immunosynergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2. Curr Trends Immunol 2012;13:51-68; PMID:23355766
    • (2012) Curr Trends Immunol , vol.13 , pp. 51-68
    • Chentoufi, A.A.1    Dervillez, X.2    Rubbo, P.A.3    Kuo, T.4    Zhang, X.5    Nagot, N.6
  • 3
    • 79953777976 scopus 로고    scopus 로고
    • Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers
    • PMID:21107439
    • Luke JM, Vincent JM, Du SX, Gerdemann U, Leen AM, Whalen RG, et al. Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers. Gene Ther 2011;18:334-43; PMID:21107439; http://dx.doi.org/10.1038/gt.2010.149
    • (2011) Gene Ther , vol.18 , pp. 334-343
    • Luke, J.M.1    Vincent, J.M.2    Du, S.X.3    Gerdemann, U.4    Leen, A.M.5    Whalen, R.G.6
  • 4
    • 33750621478 scopus 로고    scopus 로고
    • Inducible Escherichia coli fermentation for increased plasmid DNA production
    • PMID: 16819941
    • Carnes AE, Hodgson CP, Williams JA. Inducible Escherichia coli fermentation for increased plasmid DNA production. Biotechnol Appl Biochem 2006;45:155-66; PMID: 16819941; http://dx.doi.org/10.1042/BA20050223
    • (2006) Biotechnol Appl Biochem , vol.45 , pp. 155-166
    • Carnes, A.E.1    Hodgson, C.P.2    Williams, J.A.3
  • 5
    • 67650036224 scopus 로고    scopus 로고
    • Generic plasmid DNA production platform incorporating low metabolic burden seedstock and fed-batch fermentation processes
    • PMID:19408315
    • Williams JA, Luke J, Langtry S, Anderson S, Hodgson CP, Carnes AE. Generic plasmid DNA production platform incorporating low metabolic burden seedstock and fed-batch fermentation processes. Biotechnol Bioeng 2009;103:1129-43; PMID:19408315; http://dx.doi.org/10.1002/bit.22347
    • (2009) Biotechnol Bioeng , vol.103 , pp. 1129-1143
    • Williams, J.A.1    Luke, J.2    Langtry, S.3    Anderson, S.4    Hodgson, C.P.5    Carnes, A.E.6
  • 6
    • 28844490036 scopus 로고    scopus 로고
    • Bio process engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic
    • PMID:16321039
    • Hoare M, Levy MS, Bracewell DG, Doig SD, Kong S, Titchener-Hooker N, et al. Bio process engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic. Biotechnol Prog 2005;21:1577-92; PMID:16321039; http://dx.doi.org/10.1021/bp050190n
    • (2005) Biotechnol Prog , vol.21 , pp. 1577-1592
    • Hoare, M.1    Levy, M.S.2    Bracewell, D.G.3    Doig, S.D.4    Kong, S.5    Titchener-Hooker, N.6
  • 7
    • 58149141017 scopus 로고    scopus 로고
    • Plasmid DNA manufacturing technology
    • PMID:19075838
    • Carnes AE, Williams JA. Plasmid DNA manufacturing technology. Recent Pat Biotechnol 2007;1:151-66; PMID:19075838; http://dx.doi.org/10.2174/ 187220807780809436
    • (2007) Recent Pat Biotechnol , vol.1 , pp. 151-166
    • Carnes, A.E.1    Williams, J.A.2
  • 8
    • 33747123681 scopus 로고    scopus 로고
    • Successful parallel development and integration of a plasmidbased biologic, container/closure system and electrokinetic delivery device
    • PMID: 16150516
    • Hebei H, Attra H, Khan A, Draghia-Akli R. Successful parallel development and integration of a plasmidbased biologic, container/closure system and electrokinetic delivery device. Vaccine 2006;24:4607-14; PMID: 16150516; http://dx.doi.org/10.1016/j.vaccine.2005.08.049
    • (2006) Vaccine , vol.24 , pp. 4607-4614
    • Hebei, H.1    Attra, H.2    Khan, A.3    Draghia-Akli, R.4
  • 9
    • 0029874193 scopus 로고    scopus 로고
    • High cell-density culture of Escherichia coli
    • PMID:8867291
    • Lee SY. High cell-density culture of Escherichia coli. Trends Biotechnol 1996;14:98-105; PMID:8867291; http://dx.doi.org/10.1016/0167-7799 (96) 80930-9
    • (1996) Trends Biotechnol , vol.14 , pp. 98-105
    • Lee, S.Y.1
  • 10
    • 77958607925 scopus 로고    scopus 로고
    • Critical design criteria for minimal antibiotic-free plasmid vectors necessary to combine robust RNA Pol II and Pol Ill-mediated eukaryotic expression with high bacterial production yields
    • PMID:20806425
    • Carnes AE, Luke JM, Vincent JM, Anderson S, Schukar A, Hodgson CP, et al. Critical design criteria for minimal antibiotic-free plasmid vectors necessary to combine robust RNA Pol II and Pol Ill-mediated eukaryotic expression with high bacterial production yields. J Gene Med 2010;12:818-31; PMID:20806425; http://dx.doi.org/10.1002/jgm.1499
    • (2010) J Gene Med , vol.12 , pp. 818-831
    • Carnes, A.E.1    Luke, J.M.2    Vincent, J.M.3    Anderson, S.4    Schukar, A.5    Hodgson, C.P.6
  • 11
    • 78650213003 scopus 로고    scopus 로고
    • Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression
    • PMID:20830679
    • Carnes AE, Luke JM, Vincent JM, Schukar A, Anderson S, Hodgson CP, et al. Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression. Biotechnol Bioeng 2011;108:354-63; PMID:20830679; http://dx.doi.org/10.1002/bit.22936
    • (2011) Biotechnol Bioeng , vol.108 , pp. 354-363
    • Carnes, A.E.1    Luke, J.M.2    Vincent, J.M.3    Schukar, A.4    Anderson, S.5    Hodgson, C.P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.